戻る
Urogen Pharma Ltd (URGN)価格
URGN 株価推移チャート
URGN 収入
Urogen Pharma Ltd
$18.8
-3.78%
$-0.73
終値： Jan 16, 16:00:00 GMT-5
$18.8
0%
$0
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$19.54
始値
$19.64
当日レンジ
$18.66 - $20.15
52週レンジ
$3.42 - $30
取引高
575.9K
平均取引高
998.7K
1株当たり利益(TTM)
-3.31
配当利回り
--
時価総額
$880.0M
URGNとは何ですか？
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. The firm is engaged in building solutions for cancers and urologic diseases. UroGen has developed RTGelTM reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. Its lead product candidates include MitoGel and VesiGel are formulated using its proprietary reverse thermally triggered hydrogel, or RTGel, technology. MiroGel ( UGN-101) is a sustained release formulation of the chemotherapy agent Mitomycin C for the treatment of low-grade upper tract urothelial carcinoma, an urothelial cancer in the upper tract. VesiGel (UGN-102) is a sustained release formulation of a high dose Mitomycin C for the treatment of low grade non-muscle invasive bladder cancer (LG-NMIBC).